Fragile X syndrome therapy (Fulcrum Therapeutics)

N/A

Report date: 2025/03/20 15:16:36
NME

Base Information

Drug NameFragile X syndrome therapy (Fulcrum Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFragile X Messenger Ribonucleoprotein 1 stimulants
TargetsFragile X Messenger Ribonucleoprotein 1
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFulcrum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFulcrum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFragile X Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A